SATSUMA PHARMACEUTICALS INC's ticker is STSA and the CUSIP is 80405P107. A total of 46 filers reported holding SATSUMA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,269 | – | 1,815 | +6622.2% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 27 | -99.8% | 0.00% | – |
| Q2 2022 | $73,000 | +711.1% | 17,594 | +613.2% | 0.00% | – |
| Q1 2022 | $9,000 | – | 2,467 | +9768.0% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 25 | -99.2% | 0.00% | – |
| Q2 2021 | $21,000 | +110.0% | 3,005 | +74.8% | 0.00% | – |
| Q1 2021 | $10,000 | +66.7% | 1,719 | +30.7% | 0.00% | – |
| Q4 2020 | $6,000 | +50.0% | 1,315 | +38.7% | 0.00% | – |
| Q3 2020 | $4,000 | -90.2% | 948 | -33.8% | 0.00% | – |
| Q2 2020 | $41,000 | +583.3% | 1,433 | +411.8% | 0.00% | – |
| Q1 2020 | $6,000 | -94.7% | 280 | -95.1% | 0.00% | – |
| Q4 2019 | $113,000 | +1312.5% | 5,729 | +936.0% | 0.00% | – |
| Q3 2019 | $8,000 | – | 553 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 3,118,761 | $14,533,000 | 3.83% |
| Ghost Tree Capital, LLC | 904,225 | $4,214,000 | 1.23% |
| RA Capital Management | 5,914,252 | $27,560,000 | 0.38% |
| Vivo Capital, LLC | 1,232,394 | $5,743,000 | 0.26% |
| Nan Fung Group Holdings Ltd | 142,900 | $666,000 | 0.21% |
| Ikarian Capital, LLC | 629,384 | $2,934,000 | 0.21% |
| NEA Management Company, LLC | 3,142,958 | $14,646,000 | 0.17% |
| SAMLYN CAPITAL, LLC | 1,716,067 | $7,998,000 | 0.11% |
| TPG Group Holdings (SBS) Advisors, Inc. | 1,885,939 | $8,788,000 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 90,665 | $422,000 | 0.04% |